The BSTP’s 34th Annual Scientific Meeting will, this year, be held jointly with the British Toxicology
Society (BTS) and will cover the topic of emergent epigenetic therapies.
Recently we have seen an explosion of discoveries related to the cellular regulation of phenotypes
through epigenetic mechanisms. As epigenetic changes are reversible, this offers the potential for
epigenetic therapies based on cellular reprogramming (e.g. cancer, neuro degenerative disease), with
further opportunities in the detection of microRNAs (e.g. blood, exhaled air) and their use as
The Organising Committee are working to bring experienced researchers from all over the world, as
well as leaders in the industry to discuss recent advances in epigenetic therapies. This meeting will
include talks from academic researchers investigating the role of epigenetics in various diseases.
There will also be presentations from toxicologists/pathologists working in pharmaceutical/
biotechnology companies exploring epigenetic mechanisms and their therapeutic/diagnostic